Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma
View Top Employees from Chiasma| Website | https://amrytpharma.com/ |
| Ticker | CHMA |
| Revenue | $5 million |
| Employees | 18 (14 on RocketReach) |
| Founded | 2001 |
| Phone | (914) 234-2268 |
| Fax | (781) 207-2432 |
| Industry | Biotechnology Research, Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Therapeutics |
| Web Rank | 6 Million |
| Keywords | Chiasma, Chiasma Inc, Chiasma Pharma, Bongiovi Dps 2.2.0.15 Crack, Chiasma Stock |
| Competitors | Intec Pharma Ltd., Otonomy, Inc, Soligenix, Inc., Spruce Biosciences, TorreyPines Therapeutics , Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Chiasma employee's phone or email?
Chiasma Questions
The Chiasma annual revenue was $5 million in 2024.
14 people are employed at Chiasma.
The NAICS codes for Chiasma are [325, 325414, 3254, 32, 32541].
The SIC codes for Chiasma are [283, 28].
Top Chiasma Employees
-
ViewTara McCarthy
Senior Vice President, General Counsel and Secretary at Chiasma
Boston, Massachusetts, United States2 -
1
-
1
Related Companies
